Publications by authors named "Som D Mukherjee"

Claim this Profile
T
The Use of Physiotherapy Navigators in Acute Cancer Care Settings: A Scoping Review.
Holly Edward, Nelani Paramanantharajah, Neeraja Nannapaneni, Jenette Wu, Sarah Wojkowski, Som D Mukherjee

Arch Rehabil Res Clin Transl· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing exercise and self-management for women with breast cancer during treatment: results of the NEXT-BRCA randomized controlled trial.
Jenna Smith-Turchyn, Derek W Stouth, Joshua A J Keogh, Elizabeth Ball, Myanca Rodrigues, Som D Mukherjee

Sci Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of physiotherapist-led tele-rehabilitation for older adults with chronic conditions: a systematic review and meta-analysis.
Holly Edward, Daniel Nicolau, Jenette Wu, Nelani Paramanantharajah, Sarah Wojkowski, Som D Mukherjee

Disabil Rehabil· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Qualitative Study Exploring the Rehabilitation Experience of Individuals with a Previous Diagnosis of Cancer and/or Sepsis, Their Caregivers, and Health Providers.
Jenna Smith-Turchyn, Christopher Farley, Anastasia N L Newman, Jayden Pannu, Bram Rochwerg, Som D Mukherjee

Healthcare (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing physical activity for individuals with cancer during treatment: protocol for the IMPACT implementation-effectiveness trial.
Jenna Smith-Turchyn, Catherine M Sabiston, Holly Edward, Julie Richardson, Brenda K Nayiga, Som D Mukherjee

BMJ Open· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biopsychosocial Associates of Psychological Distress and Post-Traumatic Growth among Canadian Cancer Patients during the COVID-19 Pandemic.
Karen M Zhang, Som D Mukherjee, Gregory Pond, Michelle I Roque, Ralph M Meyer

Curr Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Influencing the Decision of Individuals with Breast Cancer to Join an Exercise Oncology Trial.
Jenna Smith-Turchyn, Som D Mukherjee

J Cancer Educ· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Access to Oncology Medicines in Canada: Consensus Forum for Recommendations for Improvement.
Sandeep R Sehdev, Nigel S B Rawson, Olexiy I Aseyev, Catriona J Buick, Marcus O Butler, Som D Mukherjee

Curr Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating Wall-Mounted Prompts to Facilitate Physical Activity-Related Discussion between Individuals with Cancer and Oncology Health Care Providers: A Pre-post Survey Study.
Jenna Smith-Turchyn, Som D Mukherjee, Jennifer R Tomasone, Angela J Fong, Brenda Kibuka Nayiga

Physiother Can· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-Year Outcomes Following Permissive Cardiotoxicity in Patients on Trastuzumab.
Shijie Zhou, Filipe Cirne, Justin Chow, Arman Zereshkian, Louise Bordeleau, Som D Mukherjee

Oncologist· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of Macrotroponin in Patients Receiving Treatment for Breast Cancer.
Peter A Kavsak, Brock Hoard, Katharine Mackett, Som D Mukherjee, Louise Bordeleau

CJC Open· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The European Society of Cardiology Cardio-Oncology Guidelines: Evidence Base, Actionability, and Relevance to Clinical Practice.
Darryl P Leong, Som D Mukherjee

JACC CardioOncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing Cancer Survivorship Care: Examination of Factors Associated with Transition to Primary Care.
Som D Mukherjee, Daryl Bainbridge, Christopher Hillis, Jonathan Sussman

Curr Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durvalumab Plus Olaparib in Previously Untreated, Platinum-Ineligible Patients With Metastatic Urothelial Carcinoma: A Multicenter, Randomized, Phase II Trial (BAYOU).
Jonathan E Rosenberg, Se Hoon Park, Vadim Kozlov, Tu V Dao, Daniel Castellano, Som D Mukherjee

J Clin Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Survey-Based Study on Physical Activity Promotion for Individuals with a Current or Past Diagnosis of Cancer in Canada.
Jenna Smith-Turchyn, Catherine M Sabiston, Elizabeth Ball, Som D Mukherjee

Curr Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modifiable risk factors for prostate cancer in low- and lower-middle-income countries: a systematic review and meta-analysis.
Filipe Cirne, Coralea Kappel, Shijie Zhou, Som D Mukherjee, Mahshid Dehghan

Prostate Cancer Prostatic Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of stereotactic body radiotherapy (SBRT) in oligoprogressive metastatic disease.
Sherif Ramadan, Kimmen Quan, Kara Schnarr, Rosalyn A Juergens, Sebastien J Hotte, Som D Mukherjee

Acta Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low Serum Testosterone in Men with Newly Diagnosed Androgen-Deprivation Therapy-Naïve Prostate Cancer and Its Relationship to Cardiovascular Risk Factors: A RADICAL-PC Substudy.
Jehonathan H Pinthus, Wilhelmina C M Duivenvoorden, Laurence Klotz, Som D Mukherjee, D Robert Siemens

J Urol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial.
Pamela J Goodwin, Bingshu E Chen, Karen A Gelmon, Timothy J Whelan, Marguerite Ennis, Som D Mukherjee

JAMA· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Cardiologist's Role in the Management of Patients with a Genitourinary Cancer.
Filipe Cirne, Som D Mukherjee, Jehonathan Pinthus, Darryl P Leong

Isr Med Assoc J· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What Cardio-Oncology Lessons Can We Learn From Population-Based Data?
Harry Klimis, Som D Mukherjee, Darryl P Leong

JACC CardioOncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pertuzumab Cardiotoxicity in Patients With HER2-Positive Cancer: A Systematic Review and Meta-analysis.
Muhammad Mustafa Alhussein, Abir Mokbel, Tammy Cosman, Nazanin Aghel, Eric H Yang, Som D Mukherjee

CJC Open· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ten ways to get a grip on designing and implementing a competency-based medical education training program.
Tina Hsu, Flávia De Angelis, Sohaib Al-Asaaed, Sanraj K Basi, Anna Tomiak, Som D Mukherjee

Can Med Educ J· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies for Maintaining Educational Standards in Medical Oncology Residency Training in the Era of COVID-19: Experience from a Canadian Cancer Centre.
Roochi Arora, Som D Mukherjee

J Cancer Educ· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial.
Thomas Powles, Michiel S van der Heijden, Daniel Castellano, Matthew D Galsky, Yohann Loriot, Som D Mukherjee

Lancet Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis